產(chǎn)品詳情
簡單介紹：
Anti-APOD抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-APOD抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-APOD
Cat. Number:
Anti-APOD抗體KL-10130R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apolipoprotein D (APO D), Anti-APOD抗體a glycoprotein involved in the human plasma lipid transport system. It is a progesterone binding glycoprotein of 24,000 dalton monomer molecular size, is a constituent of high density lipoprotein in plasma. The function of apolipoprotein D in the metabolism of plasma lipoproteins is unclear but the observation that this protein forms complexes with lecithin: cholesterol acyltransferase has led to the suggestion that apolipoprotein D may be involved in cholesterol esterification and transport of substrates and products of the reaction. Apolipoprotein D is expressed in a range of normal tissues including axillary apocrine glands, adrenal cortex and corpus luteum. Peripheral nerves, pituitary, testis, cerebellum and renal tubes are also positive. APO D was first isolated in large quantity as GCDFP 24, the major protein component of most human breast cyst fluids. In recent studies, Apo D immunoreactivity has been shown to be an early indicator of prostate cancer and advanced primary prostate tumors.
Also known as:
Anti-APOD抗體Apolipoprotein D; APOD; APO D; APOD protein; APOD_HUMAN; Apolipoprotein D; Apo-D; ApoD.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human APOD.
●
Predicted Molecular Weight: 19kDa.
Storage:
Shipped at 4℃, Anti-APOD抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Anti-APOD抗體Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Anti-APOD抗體Optimal working dilutions must be determined by the end user.
kl561Mu02 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Ra02 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl574Hu02 層粘連蛋白α1(LAMα1)多克隆抗體 Polyclonal Antibody to Laminin Alpha 1 (LAMa1)
kl601Mu02 髓過氧化物酶(MPO)多克隆抗體 Polyclonal Antibody to Myeloperoxidase (MPO)
kl615Mu03 纖溶抑制因子(TAFI)多克隆抗體 Polyclonal Antibody to Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
kl626Ra02 胱天蛋白酶3(CASP3)多克隆抗體 Polyclonal Antibody to Caskle 3 (CASP3)
kl672Hu02 Slit同源物2(Slit2)多克隆抗體 Polyclonal Antibody to Slit Homolog 2 (Slit2)
kl692Mu02 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl692Mu03 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl692Mu04 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl711Hu02 肝素酶(HPA)多克隆抗體 Polyclonal Antibody to Heklanase (HPA)
kl775Mu02 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl775Mu03 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl820Mu02 凝血因子Ⅱ(F2)多克隆抗體 Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra02 凝血因子Ⅱ(F2)多克隆抗體 Polyclonal Antibody to Coagulation Factor II (F2)
kl837Mu02 誘導(dǎo)型一氧化氮合酶(NOS2)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl837Mu03 誘導(dǎo)型一氧化氮合酶(NOS2)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl849Hu02 糖原磷酸化酶L(PYGL)多克隆抗體 Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)
